Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes. Doctors also prescribe it to lower the risk of cardiovascular problems in people with both type 2 diabetes and heart failure ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and lower the risk of cardiovascular problems in certain people. Mild side effects of the drug include nausea, diarrhea, and ...

greater improvements in mean HbA1c (a measure of blood glucose levels) (-1.05% vs. -0.38%; ETD -0.66% [95% CI: -0.90;-0.43]; p<0.0001), were more likely to achieve target HbA1c <7% (52.8% vs. 19.5%; ...

Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...

Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic version of Victoza ® (liraglutide injection). Liraglutide is a ...

PLAINSBORO, N.J., Novo Nordisk today announced the top-line results from the LEADER trial, which investigated the cardiovascular safety of Victoza ® (liraglutide [rDNA origin] injection) over a period ...

In a global move, Indian pharmaceutical company, Lupin on Friday has launched a generic diabetes medication in the US market. It has launched Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient ...

Saxenda and Victoza are brand-name injection pens that contain the same active drug, liraglutide. Saxenda is used for weight management. Victoza is used to treat type 2 diabetes and to lower the risk ...

A woman who’s been on a drug similar to Ozempic for nearly a decade is sharing what she’s learned. Danielle Payton, 33, is believed to be one of the longest-serving patients on a GLP-1 injection. The ...

Hikma recently received the Food and Drug Administration’s permission for a new generic, and the company also launched two new generic products. The FDA approved Hikma's first generic referencing ...

Branded content furnished by our promotional partners. The Daily Sundial editorial staff is not involved in its production. Content does not reflect the views or opinions of the editorial staff.